N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide

C112H119Cl5F2N26O12S4 — CID 159308306

IUPACN-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide
SMILESCC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(N(C)S(=O)(=O)C4CC4)cn23)CC1.CC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(N4CCCCS4(=O)=O)cn23)CC1.CN(c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCNC(=O)C3)n2c1)S(C)(=O)=O.CN(c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCn4ncnc4C3)n2c1)S(C)(=O)=O.Fc1cncc(F)c1-c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCOCC3)n2c1
InChIInChI=1S/2C24H28ClN5O3S.C23H19ClF2N4O.C21H22ClN7O2S.C20H22ClN5O3S/c1-17(31)29-13-11-28(12-14-29)16-22-24(18-3-5-19(25)6-4-18)26-23-10-7-20(15-30(22)23)27(2)34(32,33)21-8-9-21;1-18(31)28-13-11-27(12-14-28)17-22-24(19-4-6-20(25)7-5-19)26-23-9-8-21(16-29(22)23)30-10-2-3-15-34(30,32)33;24-17-4-1-15(2-5-17)23-20(14-29-7-9-31-10-8-29)30-13-16(3-6-21(30)28-23)22-18(25)11-27-12-19(22)26;1-26(32(2,30)31)17-7-8-19-25-21(15-3-5-16(22)6-4-15)18(28(19)11-17)12-27-9-10-29-20(13-27)23-14-24-29;1-24(30(2,28)29)16-7-8-18-23-20(14-3-5-15(21)6-4-14)17(26(18)11-16)12-25-10-9-22-19(27)13-25/h3-7,10,15,21H,8-9,11-14,16H2,1-2H3;4-9,16H,2-3,10-15,17H2,1H3;1-6,11-13H,7-10,14H2;3-8,11,14H,9-10,12-13H2,1-2H3;3-8,11H,9-10,12-13H2,1-2H3,(H,22,27)
InChIKeyLCEXRWKBSPACNC-UHFFFAOYSA-N
MW2364.88 g/mol
LogP15.96
Rot. Bonds24

About N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide

N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide (PubChem CID 159308306) has the molecular formula C112H119Cl5F2N26O12S4 and a molecular weight of 2364.88 g/mol. Its IUPAC name is N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide.

Molecular Properties

Compound NameN-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide
PubChem CID159308306
Molecular FormulaC112H119Cl5F2N26O12S4
Molecular Weight2364.88 g/mol
Exact Mass2360.68
IUPAC NameN-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide
SMILESCC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(N(C)S(=O)(=O)C4CC4)cn23)CC1.CC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(N4CCCCS4(=O)=O)cn23)CC1.CN(c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCNC(=O)C3)n2c1)S(C)(=O)=O.CN(c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCn4ncnc4C3)n2c1)S(C)(=O)=O.Fc1cncc(F)c1-c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCOCC3)n2c1
InChIInChI=1S/2C24H28ClN5O3S.C23H19ClF2N4O.C21H22ClN7O2S.C20H22ClN5O3S/c1-17(31)29-13-11-28(12-14-29)16-22-24(18-3-5-19(25)6-4-18)26-23-10-7-20(15-30(22)23)27(2)34(32,33)21-8-9-21;1-18(31)28-13-11-27(12-14-28)17-22-24(19-4-6-20(25)7-5-19)26-23-9-8-21(16-29(22)23)30-10-2-3-15-34(30,32)33;24-17-4-1-15(2-5-17)23-20(14-29-7-9-31-10-8-29)30-13-16(3-6-21(30)28-23)22-18(25)11-27-12-19(22)26;1-26(32(2,30)31)17-7-8-19-25-21(15-3-5-16(22)6-4-15)18(28(19)11-17)12-27-9-10-29-20(13-27)23-14-24-29;1-24(30(2,28)29)16-7-8-18-23-20(14-3-5-15(21)6-4-14)17(26(18)11-16)12-25-10-9-22-19(27)13-25/h3-7,10,15,21H,8-9,11-14,16H2,1-2H3;4-9,16H,2-3,10-15,17H2,1H3;1-6,11-13H,7-10,14H2;3-8,11,14H,9-10,12-13H2,1-2H3;3-8,11H,9-10,12-13H2,1-2H3,(H,22,27)
InChIKeyLCEXRWKBSPACNC-UHFFFAOYSA-N
XLogP15.96
TPSA374.77 Ų
H-Bond Donors1
H-Bond Acceptors31
Rotatable Bonds24
Heavy Atoms161
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002364.88
LogP ≤ 515.96
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1031

Analyze N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide?
The IUPAC name of N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide (CID 159308306) is N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide.
What is the SMILES notation for N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide?
The canonical SMILES for N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide is CC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(N(C)S(=O)(=O)C4CC4)cn23)CC1.CC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(N4CCCCS4(=O)=O)cn23)CC1.CN(c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCNC(=O)C3)n2c1)S(C)(=O)=O.CN(c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCn4ncnc4C3)n2c1)S(C)(=O)=O.Fc1cncc(F)c1-c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCOCC3)n2c1.
What is the InChIKey of N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide?
The InChIKey is LCEXRWKBSPACNC-UHFFFAOYSA-N. The full InChI is InChI=1S/2C24H28ClN5O3S.C23H19ClF2N4O.C21H22ClN7O2S.C20H22ClN5O3S/c1-17(31)29-13-11-28(12-14-29)16-22-24(18-3-5-19(25)6-4-18)26-23-10-7-20(15-30(22)23)27(2)34(32,33)21-8-9-21;1-18(31)28-13-11-27(12-14-28)17-22-24(19-4-6-20(25)7-5-19)26-23-9-8-21(16-29(22)23)30-10-2-3-15-34(30,32)33;24-17-4-1-15(2-5-17)23-20(14-29-7-9-31-10-8-29)30-13-16(3-6-21(30)28-23)22-18(25)11-27-12-19(22)26;1-26(32(2,30)31)17-7-8-19-25-21(15-3-5-16(22)6-4-15)18(28(19)11-17)12-27-9-10-29-20(13-27)23-14-24-29;1-24(30(2,28)29)16-7-8-18-23-20(14-3-5-15(21)6-4-14)17(26(18)11-16)12-25-10-9-22-19(27)13-25/h3-7,10,15,21H,8-9,11-14,16H2,1-2H3;4-9,16H,2-3,10-15,17H2,1H3;1-6,11-13H,7-10,14H2;3-8,11,14H,9-10,12-13H2,1-2H3;3-8,11H,9-10,12-13H2,1-2H3,(H,22,27).
What are the key properties of N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide?
N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide has a molecular weight of 2364.88 g/mol, XLogP of 15.96, 24 rotatable bonds, 1 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-methylcyclopropanesulfonamide;4-[[2-(4-chlorophenyl)-6-(3,5-difluoro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;N-[2-(4-chlorophenyl)-3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;1-[4-[[2-(4-chlorophenyl)-6-(1,1-dioxothiazinan-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]ethanone;N-[2-(4-chlorophenyl)-3-[(3-oxopiperazin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide is sourced from PubChem (CID 159308306), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).